Literature DB >> 1378802

Altered content and distribution of tenascin in colitis, colon adenoma, and colorectal carcinoma.

S E Riedl1, A Faissner, P Schlag, A Von Herbay, K Koretz, P Möller.   

Abstract

Tenascin is a fibroblast product and extracellular matrix protein probably excerting a fibronectin-antagonizing role. Tenascin is broadly distributed interstitially during embryogenesis but restricted to a small range of structures in normal adult tissues. Using tenascin antibodies and an indirect immunoperoxidase method, normal colon, colitis, colon adenomas, and colorectal carcinomas were examined for tissue distribution of tenascin. Normal mucosa displayed a sparce meshwork of microfibrillar tenascin in the lamina propria. The basement membrane was tenascin negative at the bottom of the crypt and developed into a positive band steadily broadening towards the mucosal surface. In colitis, this polarity was effaced; the basement membrane was a broad tenascin-positive band nearly throughout while interstitial tenascin was moderately increased. Loss of polarity in tenascin content of the basement membrane was a constant feature of adenomas, inconsistently paralleled by structural alterations in surface qualities and continuity of tenascin pattern of the basement membrane. These were most pronounced in carcinomas, where this interface was often discontinuous and had a rough surface; in addition, interstitial tenascin was considerably increased. In carcinomas, the rough surface aspect of the tenascin pattern of the basement membrane was correlated with presence of lymph node metastases (P = 0.04). It is concluded that alterations in tenascin pattern and content reflect complex disturbances in the interaction of inflamed/neoplastic colon epithelium and underlying matrix, leading to an organoid induction of tenascin in the inflammatory context and to induction together with structural abnormalities in neoplasia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1378802     DOI: 10.1016/0016-5085(92)90827-l

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  11 in total

1.  Expression of tenascin in lymphocytic autoimmune thyroiditis.

Authors:  W Back; C Heubner; J Winter; U Bleyl
Journal:  J Clin Pathol       Date:  1997-10       Impact factor: 3.411

2.  Inflammation-induced endothelial-to-mesenchymal transition: a novel mechanism of intestinal fibrosis.

Authors:  Florian Rieder; Sean P Kessler; Gail A West; Shardul Bhilocha; Carol de la Motte; Tammy M Sadler; Banu Gopalan; Eleni Stylianou; Claudio Fiocchi
Journal:  Am J Pathol       Date:  2011-09-21       Impact factor: 4.307

3.  Laminins, tenascin and type VII collagen in colorectal mucosa.

Authors:  J Lohi; I Leivo; T Tani; T Kiviluoto; E Kivilaakso; R E Burgeson; I Virtanen
Journal:  Histochem J       Date:  1996-06

4.  Interaction of fibronectin and aggregation substance promotes adherence of Enterococcus faecalis to human colon.

Authors:  R Isenmann; M Schwarz; E Rozdzinski; C Christ; E Schmidt; P Augat; R Marre; H G Beger
Journal:  Dig Dis Sci       Date:  2002-02       Impact factor: 3.199

5.  Interaction of nitric oxide and cell adhesion molecules after 24 hours of complete ureteric obstruction in the rats on a solitary kidney.

Authors:  H Oztürk; A I Dokucu; H Buyukbayram
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

6.  Tenascin expression in inflammatory, dysplastic and neoplastic lesions of the human stomach.

Authors:  O Tiitta; P Sipponen; V Gould; I Virtanen
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

7.  Stromal tenascin distribution as a prognostic marker in colorectal cancer.

Authors:  U Kressner; G Lindmark; B Tomasini-Johansson; R Bergström; B Gerdin; L Påhlman; B Glimelius
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  Latent effects of fibronectin, alpha5beta1 integrin, alphaVbeta5 integrin and the cytoskeleton regulate pancreatic carcinoma cell IL-8 secretion.

Authors:  A G Lowrie; D M Salter; J A Ross
Journal:  Br J Cancer       Date:  2004-10-04       Impact factor: 7.640

9.  The laminin response in inflammatory bowel disease: protection or malignancy?

Authors:  Caroline Spenlé; Olivier Lefebvre; Joël Lacroute; Agnès Méchine-Neuville; Frédérick Barreau; Hervé M Blottière; Bernard Duclos; Christiane Arnold; Thomas Hussenet; Joseph Hemmerlé; Donald Gullberg; Michèle Kedinger; Lydia Sorokin; Gertraud Orend; Patricia Simon-Assmann
Journal:  PLoS One       Date:  2014-10-27       Impact factor: 3.240

10.  Immunohistochemical expression of tenascin in normal stomach tissue, gastric carcinomas and gastric carcinoma in lymph nodes.

Authors:  Y Ikeda; M Mori; K Kajiyama; Y Haraguchi; O Sasaki; K Sugimachi
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.